In silico studies on nicotinamide analogs as competitive inhibitors of nicotinamidase in methicillin-resistant Staphylococcus aureus
Molecular Diversity · 2025
DOI: 10.1007/s11030-024-11036-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Jaikee Kumar Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Structural Biology & Bioinformatics Laboratory, Department of Biosciences, Manipal University Jaipur, Jaipur-Ajmer Express Highway, Jaipur, Rajasthan…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Enzyme Inhibitors, Nicotinamidase, Niacinamide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Nicotinamidase/PncA is a member of the hydrolase enzyme family, catalyzing the de-amidation of nicotinamide (NM) to nicotinic acid (NA) via salvage pathway. Products are fed into Preiss-Handler pathway for NAD+ biosynthesis which is an important enzyme cofactor and crucial for redox balance in microorganisms. Pathogens like methicillin-resistant Staphylococcus aureus (MRSA) are NAD+ auxotroph and rely on their host environment for NAD+ precursors to synthesize NAD+. Mutations in nicotinamidase/PncA have been reported to be associated with resistance to pyrazinamide (PZA), a front-line anti-tubercular drug, underlying its importance as an important link in NAD+ biosynthesis network in pathogenic organisms such as MRSA. The conserved features of PncA and essentiality of salvage route in MRSA and the absence of this enzyme in humans and other eukaryotes are attractive options to explore therapeutics against this target. In this work, we have screened novel substrate analogs from the PubChem database using virtual screening approaches employing fingerprint tanimoto-based 2D similarity search against Staphylococcus aureus PncA (SaPncA). Identified compounds were further assessed using molecular dynamics simulations to investigate conformational stability and structural integrity. We propose two analogs, namely L28 and L33 with greater stability, favorable binding and strong binding free energies in MM-PBSA calculations. The strategy could provide an important clue in developing similar compound scaffolds as potent drug-like molecules against MRSA and other pathogenic species harboring this enzyme. Smaller scaffolds of these molecules could be attractive options for fragment-based derivatization for inhibitor discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Structural Biology & Bioinformatics Laboratory, Department of Biosciences, Manipal University Jaipur, Jaipur-Ajmer Express Highway, Jaipur, Rajasthan, 303007, India.
- Department of Chemistry, Manipal University Jaipur, Jaipur, Rajasthan, 303007, India.
- Structural Biology & Bioinformatics Laboratory, Department of Biosciences, Manipal University Jaipur, Jaipur-Ajmer Express Highway, Jaipur, Rajasthan, 303007, India. sandeepkumar.srivastava@jaipur.manipal.edu.
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Singh, J. K., Singh, J., Jha, I., Rajput, T., Srivastava, S., & Srivastava, S. K. (2025). In silico studies on nicotinamide analogs as competitive inhibitors of nicotinamidase in methicillin-resistant Staphylococcus aureus. Molecular Diversity. https://doi.org/10.1007/s11030-024-11036-y
Vancouver
Singh JK, Singh J, Jha I, Rajput T, Srivastava S, Srivastava SK. In silico studies on nicotinamide analogs as competitive inhibitors of nicotinamidase in methicillin-resistant Staphylococcus aureus. Molecular Diversity. 2025. doi:10.1007/s11030-024-11036-y
BibTeX
@article{Singh2025,
author = {Singh, Jaikee Kumar and Singh, Jai and Jha, Ishita and Rajput, Tarini and Srivastava, Saurabh and Srivastava, Sandeep Kumar},
title = {In silico studies on nicotinamide analogs as competitive inhibitors of nicotinamidase in methicillin-resistant Staphylococcus aureus},
journal = {Molecular Diversity},
year = {2025},
doi = {10.1007/s11030-024-11036-y}
}
EUVIMED